Streetbeat News

Stock Prices

AAP

LL

SPWH

In Wednesday's pre-market session, 12 consumer discretionary stocks experienced significant price movements. Gainers included LL Flooring Holdings, Kaival Brands Innovations, Jianzhi Education Tech, China Liberal Education, Faraday Future, and Unique Fabricating. Losers were Advance Auto Parts, Tupperware Brands, O'Reilly Automotive, Conn's, Sportsman's Warehouse, and F45 Training Holdings.

Portfolio Pulse from Benzinga Insights

May 31, 2023 | 1:09 pm

ARDS

BDRX

BLCM

BLTE

MRKR

VTGN

12 health care stocks experienced significant price movements during Wednesday's pre-market session, with 6 gainers and 6 losers. Notable gainers include Aridis Pharmaceuticals, VistaGen Therapeutics, and Marker Therapeutics, while notable losers include Belite Bio, Biodexa Pharmaceuticals, and Bellicum Pharmaceuticals.

Portfolio Pulse from Benzinga Insights

May 31, 2023 | 1:08 pm

DOCU

DocuSign shares are trading lower after UBS maintained a Sell rating on the stock and lowered its price target from $52 to $45.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 1:05 pm

NURO

NeuroMetrix announced clinical trial results for its Quell device in treating chemotherapy-induced peripheral neuropathy (CIPN). The trial demonstrated a significant reduction in CIPN symptoms and improved quality of life for patients.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 1:05 pm

BLUE

Grizzly Research published a report on bluebird bio, criticizing the company's management and raising concerns about its gene therapy products. The report caused bluebird bio's shares to fall.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 1:04 pm

TECK

Teck Resources shares are trading higher after a Bloomberg report indicated that Glencore is working on increasing its offering for Teck.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 1:04 pm

GMED

Analysts have provided ratings for Globus Medical (NYSE:GMED) within the last quarter, with an average price target of $64.5, implying upside from the current price of $52.61. The current average has decreased by 0.77% from the previous average price target of $65.00.

Portfolio Pulse from Benzinga Insights

May 31, 2023 | 1:03 pm

NVRO

In the last quarter, Nevro (NYSE:NVRO) received 3 somewhat bullish, 7 indifferent, and 1 somewhat bearish analyst ratings. The company has an average 12-month price target of $40.64, a 0.47% decrease from the previous average of $40.83.

Portfolio Pulse from Benzinga Insights

May 31, 2023 | 1:03 pm

AMLX

Amylyx Pharma (NASDAQ:AMLX) has received 6 bullish and 1 indifferent analyst ratings in the last quarter, with an average 12-month price target of $50.43, up 5.06% from the previous average of $48.00.

Portfolio Pulse from Benzinga Insights

May 31, 2023 | 1:02 pm

AAL

BP

BRTX

CRM

SOFI

American Airlines raises Q2 guidance, BioRestorative Therapies gets a license from NY Health Department, BP shares fall due to oil price drop, Salesforce to report Q1 earnings, and SoFi Technologies gains on US debt limit bill progress.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 1:02 pm